D
Dolby Laboratories, Inc. (DLB)
NYQ – Real Time Price. Currency in USD
55.38
-1.85 (-3.23%)
At close: May 12, 2026, 4:00 PM EDT
Find any stock by ticker or company name

NYQ – Real Time Price. Currency in USD
55.38
-1.85 (-3.23%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.98 | 2.29 | 10 | |
| Quick ratio | 2.91 | 2.02 | 10 | |
| Debt to Equity | 0.02 | 1.48 | 9.0 | |
| Debt to Assets | 0.02 | 17.28 | 9.0 | |
| Interest coverage | N/A | 49.86 | 10 | |
| Weighted average score | 9.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 1.25B | 1.30B | 1.27B | 1.35B | 1.36B |
| Gross Profit | 1.11B | 1.15B | 1.13B | 1.19B | 1.19B |
| Operating Income | 217M | 263M | 265M | 280M | 271M |
| Net Income | 184M | 201M | 262M | 255M | 244M |
| EBITDA | 321M | 358M | 352M | 379M | 373M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -1.14 | -14.1 | 1.0 |
| Next quarter | 14.63 | 15.15 | 8.5 |
| Current year | 4.23 | 1.47 | 3.5 |
| Next year | 4.13 | 7.09 | 4.5 |
| Weighted average score | 4.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 14.11 | 77.99 | 29.25 | 66.32 | 9.5 |
| Y/Y | 7.05 | 3.4 | 2.24 | -50.32 | 3.3 |
| 3y average | 2.53 | 12.3 | 36.67 | 21.62 | 7.8 |
| 5y average | 3.15 | 6.07 | 20.59 | 14.5 | 6.8 |
| Weighted average score | 6.9 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 1.85 | 1.85 | 6.0 |
| Payout ratio | 31.00 | 31.00 | 5.0 |
| 5-year dividend growth rate | 8.45 | 8.45 | 9.0 |
| Years of dividend increase | 10.00 | 10.00 | 7.0 |
| Weighted average score | 6.8 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $673.8M significantly exceed its total debt $49.7M, ensuring strong financial flexibility
Total current assets $1.4B exceed Total current liabilities $474.6M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (1.5), showcasing prudent financial management
The company has no interest-bearing debt, showcasing excellent financial strength
The company generates positive free cash flow $83.4M, supporting its financial health